As of September 1, 2021, we are pleased to be part of D.A. Davidson & Co. We will continue serving our clients as part of their full-service Investment Banking Group. Click here to learn more about our combined strengths.
×

Archive for Author: Marlin & Associates

Feb 16, 2012

Marlin & Associates advises NYSE Euronext on Acquisition of Strategic Interest in Fixnetix

Press Release 0 Comments

Dear Clients and Friends, Today, our client NYSE Euronext announced that it has agreed to acquire a strategic interest in Fixnetix Limited, the London-based provider of ultra-low latency data, co-location, trading services and risk controls.  The agreement includes an option for NYSE Euronext to acquire the remainder of Fixnetix over the next three years.  We are pleased to have been the exclusive strategic and financial advisor to NYSE Euronext on this strategically important transaction. Fixnetix, winner of the 2011 Deloitte Technology Fast50 UK, provides outsourced managed services across multiple asset classes to global banks, hedge funds and proprietary trading groups…

Read More

Feb 15, 2012

Marlin & Associates advises NaviNet, North America’s largest real-time healthcare communication network on sale to Lumeris and three leading Blues health plans

Newsletter 0 Comments

Dear Clients and Friends, Today, our client NaviNet, the nation’s largest real-time healthcare communication network, signed an agreement to be acquired by Lumeris Corporation, the innovative, cloud-based health IT provider; Pittsburgh-based, Highmark Inc., Horizon Blue Cross Blue Shield of New Jersey (Horizon), and southeastern Pennsylvania’s Independence Blue Cross (IBC). We are pleased to have been the financial advisor to NaviNet on this multi-party, transformative transaction. NaviNet securely links leading health plans, industry partners and the government to hundreds of thousands of physicians, clinicians and other healthcare professionals. More than 75 percent of the nation’s physicians are enrolled in the NaviNet…

Read More

Feb 8, 2012

Marlin & Associates: February Market Update

Newsletter 0 Comments

Dear Clients & Friends, Below is a link to our February 2012 Market Update. As you will see, it provides our sense of M&A values, activity and trends for the dozen plus technology, information and healthcare sectors that we follow. Click here for our Market Update This month we saw many small to midsize transactions and few of size – this reinforces our belief that strategics and financial sponsors are showing a willingness to pay reasonable values for complimentary firms that show scale, growth, and proprietary technology, but remain somewhat risk averse when it comes to larger deals.  We did…

Read More

Jan 12, 2012

Marlin & Associates: January Market Update

Newsletter 0 Comments

Below is a link to our January 2012 Market Update. As you will see, it provides our latest sense of M&A values, activity and trends. This month, to reflect our increased activity in Asia, we have added a sector for Asia Pacific technology companies (see page 17). Click here for our Market Update 2012 seems to be starting much as 2011, with credit markets relatively tight but plenty of interest in firms that have scale, growth, and proprietary technology.  As you will see in the pages that follow – for 2011, overall transaction volume in the sectors we serve increased…

Read More

Jan 5, 2012

Marlin & Associates adds industry veteran and Goldman Sachs alumnus, Thomas Conigliaro

New M&A Addition 0 Comments

We’re proud to announce our newest addition to the M&A team in New York, Thomas V. Conigliaro. For the past eight years, while at Goldman Sachs, Tom led “Hudson Street”, and Goldman’s investments into (and, in some cases, exits from) firms such as:  iSuppli , Lusight, Medley, Trim Tabs, QSG, Pacific Epoch, Wall Street on Demand, and Epocrates (Nasdaq: EPOC).  During this period, Tom traveled the world: vetting hundreds of companies; meeting key industry players; leading investments; serving on more than a dozen boards; and leveraging his operating experience to advise portfolio companies on ways to improve productivity and performance.…

Read More

Back to Top